<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02785549</url>
  </required_header>
  <id_info>
    <org_study_id>CIR-DISA-2016</org_study_id>
    <secondary_id>2016-001596-75</secondary_id>
    <nct_id>NCT02785549</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial to Compare the Treatment of Mild Acute Diverticulitis With or Without Antibiotics</brief_title>
  <official_title>Multicentre Controlled, Randomized Clinical Trial to Compare the Efficacy and Safety of Ambulatory Treatment of Mild Acute Diverticulitis Without Antibiotics With the Standard Treatment With Antibiotics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <brief_summary>
    <textblock>
      Patients with mild acute diverticulitis (modified Neff 0 grade), following the inclusion
      criteria and giving informed consent, will be included in the study protocol and will be
      randomly assigned to one of the treatment arms: symptomatic treatment with NSAID plus
      antibiotic vs symptomatic treatment with NSAID only. They will be followed-up at 48 hours, 7
      days, 30 days and 3 months from the onset of the episode.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the last years, traditional pathologic mechanisms of acute diverticulitis are being
      questioned and replaced by more scientifically grounded hypotheses that strongly postulate an
      inflammatory origin. Local pro-inflammatory cytokines, microbiota shifts, disturbed
      neurological intestinal signalling due to alterations in colonic neuropeptides and abnormal
      colonic motility are all being proposed as potential etiologic factors. Recent publications,
      therefore, call into question the benefits of antibiotic treatment or episodes of acute
      diverticulitis, especially for mild episodes. Furthermore, recent international guidelines
      endorse this stance in their recommendations. Moreover, recent studies provide evidence
      regarding the security of treating patients with mild acute diverticulitis as outpatients.

      The investigators think that outpatient treatment without antibiotic for mild acute
      diverticulitis is not-inferior to traditional treatment with antibiotic, measuring the
      efficacy with readmission ratio. For this reason we have designed a multicentric, randomised,
      prospective study.

      All patients seen in the emergency department with clinical signs of acute diverticulitis
      (left iliac fossa abdominal pain, peritoneal irritation signs and/or leucocytosis) will
      undergo an abdominal computed tomography to confirm the diagnosis and grade the disease
      according to severity using the modified Neff (mNeff) classification. Those with mild acute
      diverticulitis (grade 0), following the inclusion criteria and giving informed consent, will
      be included in the study protocol and will be randomly assigned to one of the treatment arms:
      symptomatic treatment with NSAID plus antibiotic vs symptomatic treatment with NSAID only.
      They will be followed-up at 48 hours, 7 days, 30 days and 3 months from the onset of the
      episode.

      Primary goal is to determine if, in mild acute diverticulitis, the treatment without
      antibiotic is not-inferior to the traditional treatment with antibiotic considering
      readmission ratio.

      Secondary goals include the analysis of the differences between groups, in case there are, in
      relation to number and reason for reconsultation, reason for readmission (bad symptoms
      control, radiologic progression, analysis worsening), pain control (analogic visual scale),
      recuperation after the acute episode, complication rate and their treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Readmission ratio</measure>
    <time_frame>3 months</time_frame>
    <description>Primary outcome is to determine if, in mild acute diverticulitis, the treatment without antibiotic is not-inferior to the traditional treatment with antibiotic considering readmission ratio.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reconsultation ratio</measure>
    <time_frame>3 months</time_frame>
    <description>The analysis of the differences between groups, in case there are, in relation to number and reason for reconsultation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reason for reconsultation</measure>
    <time_frame>3 months</time_frame>
    <description>The analysis of the differences between groups, in case there are, in relation to number and reason for reconsultation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reason for readmission</measure>
    <time_frame>3 months</time_frame>
    <description>The analysis of the differences between groups, in case there are, in relation to reason for readmission (bad symptoms control, radiologic progression, analysis worsening)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain control</measure>
    <time_frame>48 hours, 7 days, 1 month, 3 months</time_frame>
    <description>The analysis of the differences between groups, in case there are, in relation to pain control (analogic visual scale), during follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>3 months</time_frame>
    <description>Description of the complications in both groups (perforation, abscess) and its treatment (percutaneous drainage, emergency surgery, broad spectrum antibiotics)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">460</enrollment>
  <condition>Acute Diverticulitis</condition>
  <arm_group>
    <arm_group_label>Symptomatic treatment with NSAID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 g/8 h acetaminophen alternating with 600 mg/8 h ibuprofen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antibiotic+symptomatic treatment with NSAID</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>875/125mg /8h amoxicillin/clavulanic acid and symptomatic treatment with 1 g/8 h acetaminophen alternating with 600 mg/8 h ibuprofen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>600 mg/8hours</description>
    <arm_group_label>Symptomatic treatment with NSAID</arm_group_label>
    <arm_group_label>Antibiotic+symptomatic treatment with NSAID</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>1 g/8 hours</description>
    <arm_group_label>Symptomatic treatment with NSAID</arm_group_label>
    <arm_group_label>Antibiotic+symptomatic treatment with NSAID</arm_group_label>
    <other_name>Paracetamol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin/clavulanic acid</intervention_name>
    <description>875mg/125mg/8 hours</description>
    <arm_group_label>Antibiotic+symptomatic treatment with NSAID</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient's written informed consent. Adequate cognitive capacity.

          -  Adequate family support

          -  No acute diverticulitis episode in the last 3 months

          -  mNeff 0 acute diverticulitis (abdominal computed tomography scan)

          -  No antibiotic treatment in the last 2 weeks

          -  Immunocompetence*

          -  No significant comorbidities**

          -  Good oral tolerance

          -  Good symptom control

          -  Maximum one of the following SIRS criteria (* T&gt;38 ºC or &lt;36ºC, L&gt;12,000 or &lt;4000/uL,
             HR&gt;90 bpm, RR&lt;20 rpm) or CRP&gt;15 mg/dL

        Exclusion Criteria:

          -  Women in pregnancy or breastfeeding

          -  Age &lt;18 years or &gt; 80 years.

          -  Absence of the patient's written informed consent. Inadequate cognitive capacity.

          -  Inadequate family support

          -  Acute diverticulitis episode in the last 3 months

          -  Moderate acute diverticulitis (mNeff grade I or upper)

          -  Antibiotic treatment in the last 2 weeks

          -  Inflammatory bowel disease

          -  Immunodepression*

          -  Presence of significant comorbidities**

          -  Bad oral tolerance

          -  Poor symptom control

          -  More than one of the following SIRS criteria (* T&gt;38 ºC or &lt;36ºC, L&gt;12,000 or
             &lt;4000/uL, HR&gt;90 bpm, RR&lt;20 rpm) or CRP&gt;15 mg/dL

        (*) Immunocompetence is the absence and immunodepression is the presence of any of the
        following: active neoplastic disease/hematologic malignancy/HIV with low CD4+
        count/long-term corticosteroid treatment/immunosuppressant
        therapy/transplant/splenectomy/genetic immunodeficiency.

        (**) We consider significant comorbidities any of the following: poorly controlled diabetes
        mellitus (HbA1&gt;7mg/dl), cardiologic event in the last 3 months, decompensation of
        hepatopathy in the last 3 months, renal chronic insufficiency in dialysis programme.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Neus Ruiz, MD</last_name>
    <email>Mnruiz@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Corporació Sanitària Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NEUS RUIZ</last_name>
      <phone>0034937231010</phone>
      <phone_ext>21490</phone_ext>
      <email>mnruiz@tauli.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Strate LL, Modi R, Cohen E, Spiegel BM. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am J Gastroenterol. 2012 Oct;107(10):1486-93. doi: 10.1038/ajg.2012.194. Epub 2012 Jul 10. Review.</citation>
    <PMID>22777341</PMID>
  </reference>
  <reference>
    <citation>Daniels L, Budding AE, de Korte N, Eck A, Bogaards JA, Stockmann HB, Consten EC, Savelkoul PH, Boermeester MA. Fecal microbiome analysis as a diagnostic test for diverticulitis. Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1927-36. doi: 10.1007/s10096-014-2162-3. Epub 2014 Jun 4.</citation>
    <PMID>24894339</PMID>
  </reference>
  <reference>
    <citation>Espín F, Rofes L, Ortega O, Clavé P, Gallego D. Nitrergic neuro-muscular transmission is up-regulated in patients with diverticulosis. Neurogastroenterol Motil. 2014 Oct;26(10):1458-68. doi: 10.1111/nmo.12407. Epub 2014 Aug 11.</citation>
    <PMID>25109425</PMID>
  </reference>
  <reference>
    <citation>Humes DJ, Simpson J, Smith J, Sutton P, Zaitoun A, Bush D, Bennett A, Scholefield JH, Spiller RC. Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation. Neurogastroenterol Motil. 2012 Apr;24(4):318-e163. doi: 10.1111/j.1365-2982.2011.01863.x. Epub 2012 Jan 25.</citation>
    <PMID>22276853</PMID>
  </reference>
  <reference>
    <citation>Chabok A, Påhlman L, Hjern F, Haapaniemi S, Smedh K; AVOD Study Group. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg. 2012 Apr;99(4):532-9. doi: 10.1002/bjs.8688. Epub 2012 Jan 30.</citation>
    <PMID>22290281</PMID>
  </reference>
  <reference>
    <citation>Isacson D, Thorisson A, Andreasson K, Nikberg M, Smedh K, Chabok A. Erratum to: Outpatient, non-antibiotic management in acute uncomplicated diverticulitis: a prospective study. Int J Colorectal Dis. 2015 Sep;30(9):1235. doi: 10.1007/s00384-015-2284-9.</citation>
    <PMID>26084881</PMID>
  </reference>
  <reference>
    <citation>Estrada Ferrer O, Ruiz Edo N, Hidalgo Grau LA, Abadal Prades M, Del Bas Rubia M, Garcia Torralbo EM, Heredia Budo A, Suñol Sala X. Selective non-antibiotic treatment in sigmoid diverticulitis: is it time to change the traditional approach? Tech Coloproctol. 2016 May;20(5):309-15. doi: 10.1007/s10151-016-1464-0. Epub 2016 Apr 6.</citation>
    <PMID>27053254</PMID>
  </reference>
  <reference>
    <citation>Brochmann ND, Schultz JK, Jakobsen GS, Øresland T. Management of acute uncomplicated diverticulitis without antibiotics: a single-centre cohort study. Colorectal Dis. 2016 Nov;18(11):1101-1107. doi: 10.1111/codi.13355.</citation>
    <PMID>27089051</PMID>
  </reference>
  <reference>
    <citation>Unlü C, de Korte N, Daniels L, Consten EC, Cuesta MA, Gerhards MF, van Geloven AA, van der Zaag ES, van der Hoeven JA, Klicks R, Cense HA, Roumen RM, Eijsbouts QA, Lange JF, Fockens P, de Borgie CA, Bemelman WA, Reitsma JB, Stockmann HB, Vrouenraets BC, Boermeester MA; Dutch Diverticular Disease 3D Collaborative Study Group. A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial). BMC Surg. 2010 Jul 20;10:23. doi: 10.1186/1471-2482-10-23.</citation>
    <PMID>20646266</PMID>
  </reference>
  <reference>
    <citation>Andersen JC, Bundgaard L, Elbrønd H, Laurberg S, Walker LR, Støvring J; Danish Surgical Society. Danish national guidelines for treatment of diverticular disease. Dan Med J. 2012 May;59(5):C4453.</citation>
    <PMID>22549495</PMID>
  </reference>
  <reference>
    <citation>Andeweg CS, Mulder IM, Felt-Bersma RJ, Verbon A, van der Wilt GJ, van Goor H, Lange JF, Stoker J, Boermeester MA, Bleichrodt RP; Netherlands Society of Surgery; Working group from Netherlands Societies of Internal Medicine, Gastroenterologists, Radiology, Health echnology Assessment and Dieticians. Guidelines of diagnostics and treatment of acute left-sided colonic diverticulitis. Dig Surg. 2013;30(4-6):278-92. doi: 10.1159/000354035. Epub 2013 Aug 20. Review.</citation>
    <PMID>23969324</PMID>
  </reference>
  <reference>
    <citation>Cuomo R, Barbara G, Pace F, Annese V, Bassotti G, Binda GA, Casetti T, Colecchia A, Festi D, Fiocca R, Laghi A, Maconi G, Nascimbeni R, Scarpignato C, Villanacci V, Annibale B. Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterol J. 2014 Oct;2(5):413-42. doi: 10.1177/2050640614547068.</citation>
    <PMID>25360320</PMID>
  </reference>
  <reference>
    <citation>Kruis W, Germer CT, Leifeld L; German Society for Gastroenterology, Digestive and Metabolic Diseases and The German Society for General and Visceral Surgery. Diverticular disease: guidelines of the german society for gastroenterology, digestive and metabolic diseases and the german society for general and visceral surgery. Digestion. 2014;90(3):190-207. doi: 10.1159/000367625. Epub 2014 Nov 19. Review.</citation>
    <PMID>25413249</PMID>
  </reference>
  <reference>
    <citation>Mora Lopez L, Serra Pla S, Serra-Aracil X, Ballesteros E, Navarro S. Application of a modified Neff classification to patients with uncomplicated diverticulitis. Colorectal Dis. 2013 Nov;15(11):1442-7. doi: 10.1111/codi.12449.</citation>
    <PMID>24192258</PMID>
  </reference>
  <reference>
    <citation>Alonso S, Pera M, Parés D, Pascual M, Gil MJ, Courtier R, Grande L. Outpatient treatment of patients with uncomplicated acute diverticulitis. Colorectal Dis. 2010 Oct;12(10 Online):e278-82. doi: 10.1111/j.1463-1318.2009.02122.x.</citation>
    <PMID>19906059</PMID>
  </reference>
  <reference>
    <citation>Biondo S, Golda T, Kreisler E, Espin E, Vallribera F, Oteiza F, Codina-Cazador A, Pujadas M, Flor B. Outpatient versus hospitalization management for uncomplicated diverticulitis: a prospective, multicenter randomized clinical trial (DIVER Trial). Ann Surg. 2014 Jan;259(1):38-44. doi: 10.1097/SLA.0b013e3182965a11.</citation>
    <PMID>23732265</PMID>
  </reference>
  <reference>
    <citation>Gargallo Puyuelo CJ, Sopeña F, Lanas Arbeloa A. Colonic diverticular disease. Treatment and prevention. Gastroenterol Hepatol. 2015 Dec;38(10):590-9. doi: 10.1016/j.gastrohep.2015.03.010. Epub 2015 May 12. Review.</citation>
    <PMID>25979437</PMID>
  </reference>
  <reference>
    <citation>Mäkelä JT, Klintrup K, Rautio T. The role of low CRP values in the prediction of the development of acute diverticulitis. Int J Colorectal Dis. 2016 Jan;31(1):23-7. doi: 10.1007/s00384-015-2410-8. Epub 2015 Oct 31.</citation>
    <PMID>26519151</PMID>
  </reference>
  <reference>
    <citation>Mäkelä JT, Klintrup K, Takala H, Rautio T. The role of C-reactive protein in prediction of the severity of acute diverticulitis in an emergency unit. Scand J Gastroenterol. 2015 May;50(5):536-41. doi: 10.3109/00365521.2014.999350. Epub 2015 Feb 9.</citation>
    <PMID>25665622</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2016</study_first_submitted>
  <study_first_submitted_qc>May 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2016</study_first_posted>
  <last_update_submitted>January 9, 2017</last_update_submitted>
  <last_update_submitted_qc>January 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Neus Ruiz-Edo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Acute diverticulitis</keyword>
  <keyword>Antibiotic</keyword>
  <keyword>Outpatient treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diverticulitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

